Nanoparticles as Novel Emerging Therapeutic Antibacterial Agents in the Antibiotics Resistant Era

Biol Trace Elem Res. 2021 Jul;199(7):2552-2564. doi: 10.1007/s12011-020-02394-3. Epub 2020 Oct 6.

Abstract

Microorganisms are highly resistant to the antibiotics that are commonly used and thus are becoming serious public health problem. There is an urgent need for new approaches to monitor microbial behavior, and hence, nanomaterial can be a very promising solution. Nanotechnology has led to generation of novel antimicrobial agents such as gold, silver, zinc, copper, poly-£-lysine, iron, and chitosan which have shown remarkable potential, demonstrating their applicability as proficient antibiotic agents against various pathogenic bacterial species. The antimicrobial nanoproduct physically kills the organism's cell membranes that prevent the production of drug-resistant microorganisms. These nanosized particles can also be used as diagnostic agents, targeted drug delivery vehicle, noninvasive imaging technologies, and in vivo visual monitoring of tumors angiogenesis. These nanomaterials provide a promising platform for diagnostics, prognostic, drug delivery, and treatment of diseases by means of nanoengineered products/devices. This owes to their small size, prolonged antimicrobial efficacy with insignificant toxicity creating less environmental hazard or toxicity. Scientists address several problems such as health, bioethical problems, toxicity risks, physiological, and pharmaceutical concerns related with the usage of NPs as antimicrobial agents as current research lack adequate data and information on the safe use of certain tools and materials.

Keywords: Antibiotic resistance; Antimicrobial; Environmental hazard; Multidrug resistance; Nanoparticles; Toxicity.

Publication types

  • Review

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Gold
  • Metal Nanoparticles*
  • Nanoparticles*
  • Nanotechnology
  • Silver

Substances

  • Anti-Bacterial Agents
  • Silver
  • Gold